A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 134-141

  Ndhlovu, Lishomwa C ^a   Leal, Fabio E ^a,b   Eccles James, Ijeoma G ^a   Jha, Aashish R ^a   Lanteri, Marion ^c   Norris, Philip J ^a,c   Barbour, Jason D ^a   Wachter, Douglas J ^a   Andersson, Jan ^d   Taskén, Kjetil ^e   Torheim, Eirik A ^e   Aandahl, Einar M ^e   Kallas, Esper G ^b   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

CD25; CD39; FOXP3; Inducer; Proliferation

Indexed keywords

CD39 ANTIGEN; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHORYLASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APYRASE; CYTOKINE; LEUKOCYTE ANTIGEN;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY;

ANTIGENS, CD; APYRASE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; HUMANS; T-LYMPHOCYTE SUBSETS;

EID: 74249119113     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939258     Document Type: Article

References (30)

1. von Herrath, M. G. and Harrison, L. C., Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 2003. 3: 223-232.
2. Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M. et al., Crucial role of FOXP3 in the development and function of human CD25+CD4+regulatory T cells. Int. Immunol. 2004. 16: 1643-1656.
3. Mills, K. H., Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004. 4: 841-855.
4. Shevach, E. M., Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 2000. 18: 423-449.
5. Wood, K. J. and Sakaguchi, S., Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 199-210.
6. Nixon, D. F., Aandahl, E. M. and Michaelsson, J., CD4+CD25+regulatory T cells in HIV infection. Microbes Infect. 2005. 7: 1063-1065.
7. Zou, W., Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006. 6: 295-307.
8. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25 (+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
9. Belkaid, Y. and Rouse, B. T., Natural regulatory T cells in infectious disease. Nat. Immunol. 2005. 6: 353-360.
10. Sakaguchi, S., Naturally arising CD4+regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
11. Ndhlovu, L. C., Loo, C. P., Spotts, G., Nixon, D. F. and Hecht, F. M., FOXP3 expressing CD127lo CD4+T cells inversely correlate with CD38+CD8+T cell activation levels in primary HIV-1 infection. J. Leukoc. Biol. 2008. 83: 254-262.
12. Green, D. R., Chue, B. and Gershon, R. K., Discrimination of 2 types of suppressor T cells by cell surface phenotype and by function: the ability to regulate the contrasuppressor circuit. J. Mol. Cell Immunol. 1983. 1: 19-30.
13. Gershon, R. K., Eardley, D. D., Durum, S., Green, D. R., Shen, F. W., Yamauchi, K., Cantor, H. and Murphy, D. B., Contrasuppression. A novel immunoregulatory activity. J. Exp. Med. 1981. 153: 1533-1546.
14. Lehner, T., Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation. Immunology 2008. 123: 40-44.
15. Athanassakis, I. and Vassiliadis, S., T-regulatory cells: are we rediscovering T suppressors? Immunol. Lett. 2002. 84: 179-183.
16. Nabel, G., Greenberger, J. S., Sakakeeny, M. A. and Cantor, H., Multiple biologic activities of a cloned inducer T-cell population. Proc. Natl. Acad. Sci. USA 1981. 78: 1157-1161.
17. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
18. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
19. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
20. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Hopner, S. et al., Expression of ectonucleotidase CD39 by Foxp3+Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007. 110: 1225-1232.
21. Rowe, M., Hildreth, J. E., Rickinson, A. B. and Epstein, M. A., Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int. J. Cancer. 1982. 29: 373-381.
22. Marcus, A. J., Broekman, M. J., Drosopoulos, J. H., Islam, N., Alyonycheva, T. N., Safier, L. B., Hajjar, K. A. et al., The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J. Clin. Invest. 1997. 99: 1351-1360.
23. Enjyoji, K., Sevigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch 2nd, J. S., Imai, M. et al., Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 1999. 5: 1010-1017.
24. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 1693-1700.
25. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells. J. Exp. Med. 2006. 203: 1701-1711.
26. Grinthal, A. and Guidotti, G., CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? Purinergic Signal 2006. 2: 391-398.
27. Musi, E., Islam, N. and Drosopoulos, J. H., Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants. Arch. Biochem. Biophys. 2007. 461: 30-39.
28. Reiner, S. L., Decision making during the conception and career of CD4+T cells. Nat. Rev. Immunol. 2009. 9: 81-82.
29. Aandahl, E. M., Moretto, W. J., Haslett, P. A., Vang, T., Bryn, T., Tasken, K. and Nixon, D. F., Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 2002. 169: 802-808.
30. Bours, M. J., Swennen, E. L., Di Virgilio, F., Cronstein, B. N. and Dagnelie, P. C., Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 2006. 112: 358-404.